FITB
63
3
AXP
71
2
WBA
48
4
AON
54
2
GOOGL
40
-5
TJX
64
2
KMB
39
2
LB
63
22
HST
49
-9
CSX
60
3
AIV
72
2
CMG
72
5
ACN
52
3
ORCL
65
-2
URI
65
5
DOW
44
10
COF
60
2
GOOG
50
-3
CF
57
-2
NRG
49
-3
FITB
63
3
AXP
71
2
WBA
48
4
AON
54
2
GOOGL
40
-5
TJX
64
2
KMB
39
2
LB
63
22
HST
49
-9
CSX
60
3
AIV
72
2
CMG
72
5
ACN
52
3
ORCL
65
-2
URI
65
5
DOW
44
10
COF
60
2
GOOG
50
-3
CF
57
-2
NRG
49
-3
Financhill
Back

Verrica Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
32

VRCA
Verrica Pharmaceuticals

Last Price:
1.00
Seasonality Move:
50.34%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
32
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $0.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 42.74 Sell
Chaikin Money Flow: 81325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.82 - 1.5) Sell
Bollinger Bands (100): (0.69 - 5.69) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.9 Buy
20-day SMA: 1.07 Sell
50-day SMA: 1.36 Sell
200-day SMA: 5.01 Sell
8-day EMA: 0.94 Buy
20-day EMA: 1.05 Sell
50-day EMA: 1.62 Sell
200-day EMA: 3.98 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):